In a 74-year-old patient with obstructive sleep apnea who refuses CPAP after multiple failed attempts, is it appropriate to try temazepam for insomnia?

Do Not Use Temazepam in This Patient

I strongly recommend against prescribing temazepam for this 74-year-old patient with untreated obstructive sleep apnea (OSA). Benzodiazepines, including temazepam, carry significant risks in OSA patients, particularly for acute respiratory failure, and this represents a contraindication in the context of untreated sleep apnea 1.

Critical Safety Concerns

Respiratory Depression Risk in Untreated OSA

The most concerning issue is that benzodiazepine use in OSA patients significantly increases the risk of acute respiratory failure. A large retrospective study found that recent benzodiazepine use was associated with a 28.6-fold increased risk of acute respiratory failure in OSA patients (OR = 28.6; 95% CI = 5.24-156), and even long-term use carried a 10.1-fold increased risk 2. This is a life-threatening complication that far outweighs any potential sleep benefit.

The FDA label explicitly warns that temazepam can cause drowsiness and decreased level of consciousness, with elderly patients at particularly high risk 1. When combined with untreated OSA—which already causes repetitive upper airway collapse and oxygen desaturation—adding a respiratory depressant creates a dangerous synergy.

Age-Specific Vulnerabilities

At 74 years old, this patient faces compounded risks:

• Falls and fractures: Elderly patients on benzodiazepines have substantially higher fall risk 1
• Cognitive impairment: Temazepam can worsen confusion, memory, and attention in older adults 1
• Complex sleep behaviors: Risk of sleep-driving, sleep-walking, and other dangerous parasomnias 1
• Paradoxical agitation: Elderly patients may experience aggression, abnormal behavior, and worsening depression 1, 3

What You Should Do Instead

1. Address the OSA First (Non-CPAP Options)

Since CPAP has failed, consider these evidence-based alternatives:

Mandibular Advancement Devices (MADs): Guidelines support MADs as effective alternatives to CPAP, with equivalent improvements in daytime sleepiness, quality of life, and patient preference—particularly important given CPAP intolerance 4. Veterans with OSA and comorbid conditions showed greater adherence to MADs over CPAP.

Positional Therapy: If her OSA is position-dependent, this simple intervention is recommended 5.

Weight Management: Active weight management with a BMI-based stepwise strategy is recommended for all OSA patients 5.

2. Treat Insomnia Safely in the Context of OSA

Cognitive Behavioral Therapy for Insomnia (CBT-I): This is the first-line treatment for chronic insomnia, even in patients with comorbid OSA 4. Studies show that combination therapy (CBT-I plus OSA treatment) produces greater improvements than either alone 6. Telehealth delivery is effective and increases access 4.

If Pharmacotherapy is Necessary:

• Non-benzodiazepine hypnotics (Z-drugs like zolpidem, eszopiclone, zaleplon) have been studied in OSA patients and show minimal effect on apnea-hypopnea index while improving sleep 7, 6. The American Academy of Sleep Medicine suggests these agents for sleep onset and maintenance insomnia 7.
• However, these should only be used after OSA treatment is initiated or under close monitoring 5.
• Benzodiazepines are explicitly not recommended for comorbid insomnia and OSA (COMISA) 5.

3. Consider Emerging OSA Pharmacotherapy

Recent evidence supports pharmacologic options for OSA itself:

• GLP-1 receptor agonists (tirzepatide) for patients with obesity and moderate-to-severe OSA show improvements in apnea-hypopnea index and sleep outcomes 5, 8, 9
• Atomoxetine-oxybutynin combination reduces OSA severity through increased pharyngeal muscle tone 8, 9

Common Pitfalls to Avoid

1. Don't assume "failed sleeping medications" means benzodiazepines are the next step—they represent escalation to a more dangerous class in this context
2. Don't underestimate OSA severity in elderly patients—they often present with atypical symptoms (less snoring, more nocturia, cognitive decline) 5
3. Don't treat insomnia in isolation—39-58% of OSA patients have insomnia symptoms; treating one without the other leads to poor outcomes 6
4. Don't use temazepam even at low doses—while one small study showed no worsening of mild OSA with 15-30mg temazepam 10, this was in carefully selected patients with RDI <10, not generalizable to clinical practice, and predates the large safety data showing respiratory failure risk 2

The Bottom Line

Your priority must be preventing morbidity and mortality. The evidence clearly demonstrates that benzodiazepines in untreated OSA patients create unacceptable respiratory risk, particularly in elderly individuals. Focus on alternative OSA treatments (MADs, positional therapy, weight loss) combined with CBT-I for insomnia. Only after OSA is adequately treated should you cautiously consider non-benzodiazepine hypnotics if behavioral interventions fail.